Keyphrases
Malignant Mesothelioma
100%
Chimeric Antigen Receptor T Cells (CAR-T)
100%
Specific Antigen
100%
T Cell Targeting
100%
Mesothelioma Cells
30%
Monoclonal Antibody
15%
4-1BB
15%
Co-stimulatory Domain
15%
Target Antigen
7%
High Sensitivity
7%
Novel Therapeutics
7%
Therapeutic Approaches
7%
High Specificity
7%
Xenograft Mouse Model
7%
Tumor Growth in Vivo
7%
Anti-apoptotic Proteins
7%
Phenotypical
7%
Continuous Growth
7%
CD28
7%
Reporter Assay
7%
Diagnostic Marker
7%
Gene Expression Profiling
7%
Signaling Pathway Activation
7%
NF-κB Signaling
7%
Killing Activity
7%
Tim-3
7%
PD-1 Expression
7%
CCR7
7%
Self-activation
7%
BAK1
7%
Memory Markers
7%
In Vitro Killing
7%
Early Memories
7%
Tonic Signaling
7%
TCF7
7%
Differential Signaling
7%
Immunology and Microbiology
T Cell
100%
Antigen Specificity
100%
Chimeric Antigen Receptor T-Cell
100%
Chimeric Antigen Receptor
100%
Monoclonal Antibody
20%
Mesothelioma Cell Line
20%
Upregulation
10%
Mouse Model
10%
Xenograft
10%
Downregulation
10%
Signal Transduction
10%
CD28
10%
NFAT
10%
Immunology
10%
Gene Expression Assay
10%